ICD   PCS   Disclaimer
PCS-2023 Procedure Codes Overview
PCS-2023 > X > XW > XW0 > XW01
XW0

Anatomical Regions, Introduction

Info:
Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
XW01

Introduction, Subcutaneous Tissue

XW013
Percutaneous
XW0131
Daratumumab and Hyaluronidase-fihj
XW01318
Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8
XW0134
Teclistamab Antineoplastic
XW01348
Introduction of Teclistamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8
XW0139
Satralizumab-mwge
XW01397
Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7
XW013F
Other New Technology Therapeutic Substance
XW013F5
Introduction of Other New Technology Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5
XW013H
Other New Technology Monoclonal Antibody
XW013H6
Introduction of Other New Technology Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
XW013K
Leronlimab Monoclonal Antibody
XW013K6
Introduction of Leronlimab Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
XW013S
COVID-19 Vaccine Dose 1
XW013S6
Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
XW013T
COVID-19 Vaccine Dose 2
XW013T6
Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
XW013U
COVID-19 Vaccine
XW013U6
Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
XW013V
COVID-19 Vaccine Dose 3
XW013V7
Introduction of COVID-19 Vaccine Dose 3 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7
XW013W
Caplacizumab
XW013W5
Introduction of Caplacizumab into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5
XW013W7
Introduction of COVID-19 Vaccine Booster into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7
XW01X
External
XW01X2
Bromelain-enriched Proteolytic Enzyme
XW01X27
Introduction of Bromelain-enriched Proteolytic Enzyme into Subcutaneous Tissue, External Approach, New Technology Group 7

 

ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine